TransMedics Reports Fourth Quarter and Full Year 2021 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Dell again lifts annual forecasts as AI demand powers record results
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- Uber stock gains 2% as tech giant cuts 3,300 jobs in major restructuring
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
TransMedics Group (TMDX) PT Lowered to $28 at Cowen
February 24, 2022 6:56 AM ESTCowen analyst Joshua Jennings lowered the price target on TransMedics Group (NASDAQ: TMDX) to $28.00 (from $29.00) while maintaining an Outperform rating.
The analyst commented, "TMDX reported 4Q sales of $9.7M, up 27%, vs the $7.5M consensus. It introduced 2022 sales guidance of $49M-$55M, reflecting... More
TransMedics Group (TMDX) Misses Q4 EPS by 4c
February 23, 2022 4:28 PM ESTTransMedics Group (NASDAQ: TMDX) reported Q4 EPS of ($0.46), $0.04 worse than the analyst estimate of ($0.42). Revenue for the quarter came in at $9.7 million versus the consensus estimate of $7.52 million.
For earnings history and earnings-related data on TransMedics Group (TMDX) click here.
... More